Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
Viala K, Renié L, Maisonobe T, Béhin A, Neil J, Léger JM, Bouche P. Viala K, et al. Brain. 2004 Sep;127(Pt 9):2010-7. doi: 10.1093/brain/awh222. Epub 2004 Aug 2. Brain. 2004. PMID: 15289267
We report the clinical, biological and electrophysiological features, the course and the response to treatment in 23 LSS patients. The initial symptoms started in the distal part of an upper limb in 70% of patients. They were sensorimotor in 65% and purely se …
We report the clinical, biological and electrophysiological features, the course and the response to treatment in 23 LSS patients. The initi …
Prospective Cohort Study of Nusinersen Treatment in Adults with Spinal Muscular Atrophy.
Yeo CJJ, Simeone SD, Townsend EL, Zhang RZ, Swoboda KJ. Yeo CJJ, et al. J Neuromuscul Dis. 2020;7(3):257-268. doi: 10.3233/JND-190453. J Neuromuscul Dis. 2020. PMID: 32333595
BACKGROUND: The impact of nusinersen therapy on outcomes in adults with Spinal Muscular Atrophy (SMA) remains uncertain. ...Primary outcomes were the Hammersmith Functional Motor Scale-Expanded (HFMSE) and the Revised Upper Limb Measure (RULM). …
BACKGROUND: The impact of nusinersen therapy on outcomes in adults with Spinal Muscular Atrophy (SMA) remains uncertain …